The data shows a clear shift in residency selection: raw scores alone do not separate applicants the way they used to. As Step 1 became pass/fail and application inflation kept rising, research output gained signal value. Program directors still care about clinical performance, letters, and fit. Obviously. But in crowded applicant pools, they also look for measurable markers of sustained academic effort. Manuscripts do that. And "in review" manuscripts do more than most applicants realize.
I will be blunt: leaving legitimate "in review" work off your CV is usually a mistake. Not a noble display of humility. A mistake. You are hiding evidence of productivity at exactly the point in the cycle when evaluators are trying to estimate your trajectory, not just your finished products.
I have seen this play out in advising meetings every fall. Two applicants have similar scores, similar clerkship grades, similar school reputation. One CV shows accepted work plus two manuscripts in review with dates and journals. The other stops at older poster presentations. Guess which one looks more active, more organized, and more likely to keep producing. The answer is not subtle.
The Baseline: Why "In Review" is a High-Value Metric in Modern Application Pools
Understanding how faculty quietly rank these research entries can provide further context (See also: How Faculty Quietly Rank Research on Your Residency CV for more insights).
Research has become a sorting tool because the old sorting tools weakened. That is the baseline. In competitive specialties and academically oriented internal medicine programs, committees increasingly look for proof that an applicant can generate, finish, and advance scholarly work. Not just start it. Finish it.
The data shows a meaningful association between publication volume and match outcomes. Across competitive specialties, applicants with 3 or more peer-reviewed manuscripts commonly outperform those with none, with roughly a 20-25% relative advantage in match success depending on specialty and cohort. Internal medicine at research-heavy programs, dermatology, and radiology all reflect this pattern. Not because publications magically make someone a better doctor, but because they signal persistence, mentorship access, analytical thinking, and follow-through.
That is where "in review" earns its place. It is not the same as "idea discussed with mentor," and it is not the same as "submitted somewhere, maybe." Properly documented "in review" status indicates a manuscript has entered a journal workflow with a timestamp and an editorial trail. That matters. It is a much stronger status marker than vague labels such as "under consideration" or generic "submitted," which often sound padded because they are padded.
"In review" reduces uncertainty. Program directors spend a shocking amount of time filtering noise from applications. A clean citation followed by "in review," journal name, and submission month gives them something concrete: this applicant has an active scholarly pipeline right now. Not last year. Now.
There is also a psychological layer. Evaluators know academic work moves slowly. If they see accepted papers only, they see past productivity. If they also see current items in review, they see momentum. Momentum changes how an application feels. It suggests the applicant did not just stumble into one project with a generous attending; it suggests repeatable behavior. That is what committees are actually trying to identify.
Strategy 1: Quantifying Pipeline Velocity Through Transparency
Listing "in review" manuscripts lets you show pipeline velocity. That phrase sounds dry, but it is useful. Reviewers are trying to estimate whether your academic work is episodic or continuous. Dates answer that question fast.
If you list a citation followed by "Submitted January 2024; In Review March 2024," you are giving temporal anchors. The data shows that dated activity reads as credible activity. It lets an evaluator infer pace: project completion, manuscript drafting, journal targeting, and editorial progress. Without dates, a research section becomes mush. With dates, it becomes a timeline.
That matters because empty space in a CV gets interpreted harshly. I have watched faculty scan a research section and mentally ask, "Did this person stop producing?" They may never say it out loud in the interview. They are still thinking it. A gap after a research year or after multiple projects is especially damaging because it creates friction in your story. Active "in review" entries soften that gap by showing that output is still moving through the system.
The comparison is straightforward:
- No active entries: suggests past engagement, uncertain present activity
- Dated in-review entries: suggests ongoing scholarship and process discipline
- Vague undated entries: suggests possible inflation and poor documentation
The best formatting is simple and specific. Use month and year. Example:
- Patel A, Nguyen T, Smith R. Outcomes of early anticoagulation in hospitalized patients with X. Journal of Hospital Medicine. In review. Submitted 02/2024.
That line does several things at once. It signals authorship, topic relevance, target journal quality, and workflow status. Efficient. High yield.
The curve is not magic, but the trend is consistent: as documented scholarly output rises, interview invite rates tend to rise as well. The inflection point often begins once committees see not only completed work but also active pipeline evidence. "In review" helps create that effect because it makes your trajectory visible.
Strategy 2: Establishing Credibility via Peer-Validation Signals
Here is the blunt version: not all research entries are equal, and committees know it.
A preprint is not the same as a peer-reviewed manuscript. A work-in-progress line is not the same as a submitted paper. And "in review" is not the same as "I hope this becomes a paper eventually." Words matter because they imply different levels of external filtering.
The data shows that editorial triage is a real hurdle. Depending on the journal and field, roughly 60-70% of submissions may be rejected before full peer review. So when a manuscript reaches true "in review" status, it has already cleared an initial screen. That does not mean acceptance is coming. It does mean an editor decided the paper was strong enough to send to expert reviewers. That is a meaningful quality signal.
From a residency perspective, this works like borrowed credibility. Program directors may not know the full methods of your study, and they definitely are not reading your entire discussion section during committee season. But they do understand the publication pipeline. "In review" tells them your work is being evaluated by outsiders with domain expertise. That external validation matters because it reduces the risk that your CV is full of internal projects that never matured beyond local enthusiasm.
This is why I strongly prefer "in review" over mushy labels. "Under consideration" sounds evasive. "Submitted" is weaker. "In review" is cleaner and more informative if that is the true status.
There is also an integrity advantage. If the manuscript gets rejected, you update it. Simple. Move it back to "submitted" if it goes to another journal, or remove it if appropriate. This is not hard. The wrong move is leaving stale status language on your CV and hoping no one notices. People notice. Especially faculty who publish.
A credible publication section does not need to be massive. It needs to be precise.
Strategy 3: Optimizing Keyword Searchability for Electronic Screening Tools
Applicants still imagine every CV gets lovingly reviewed line by line on first pass. That is fantasy. The data shows increasing reliance on digital application review, internal database sorting, and keyword-based filtering. Even when programs do not use a classic corporate ATS, they still use structured filters, searchable PDFs, exported ERAS fields, and committee spreadsheets.
That means metadata matters.
"In review" functions as a useful keyword cluster because it sits next to the terms committees already care about: publication, manuscript, journal, research, peer review. If your CV includes active research status in standardized language, it is easier to parse both electronically and visually. If you omit it, you reduce the completeness of your research profile.
Placement matters too. Put these entries under Publications or Scientific Presentations and Publications. Do not bury them under "Professional Experience." That is bad categorization and bad strategy. Reviewers expect to find scholarly output in the research/publication section. Meet that expectation.
The practical advantage is simple:
- Better searchability in internal review systems
- Cleaner categorization for faculty skimming dozens of applications
- Stronger signal for "active research engagement"
Candidates who leave out "in review" manuscripts often think they are being conservative. What they are actually doing is making themselves less legible to the system.
Strategy 4: Managing Applicant Anxiety Through Data-Backed Norms
A lot of students hesitate because they think listing "in review" looks like they are trying too hard. That anxiety is common. It is also misplaced.
The data shows this is normal behavior among successful applicants, especially at research-oriented programs. Benchmark reviews of matched residents' CVs commonly show 1-2 items listed as "in review" or "manuscript in preparation," with "in review" carrying substantially more weight. In other words, your peers are already doing this. The polished, high-performing applicants you are competing against? Many of them are absolutely listing active manuscripts.
So stop treating factual status reporting like bragging. It is not bragging. It is process documentation.
This framing helps with imposter syndrome too. You are not claiming acceptance. You are not claiming impact factor prestige by association. You are stating a verifiable stage in the publication cycle. That is all. A factual line on a CV. Clean. Defensible.
I also advise applicants to track their own publication funnel:
- Number submitted
- Number sent to review
- Number rejected at desk
- Number revised
- Number accepted
- Median time from submission to decision
Why? Because your own data becomes strategy. If your last five manuscripts had a 20% send-out rate at one journal tier and a 60% send-out rate at another, that tells you something about targeting. Smarter journal selection improves throughput, and throughput improves the story your CV tells over time.
Strategy 5: Turning "In Review" Into Interview-Ready Evidence of Follow-Through
This final point is where the value compounds. "In review" does not just fill a line on your CV. It gives you interview material. And that matters because interviewers often probe the most recent item, not the oldest accepted paper.
When you list an active manuscript, you create an opening to discuss:
- Why the question mattered
- What your actual role was
- Which methods you used
- What the likely reviewer concerns are
- How the work connects to your specialty choice
That is gold in interviews. Fresh projects are easier to discuss with energy and detail. They also make you sound current rather than archival. I have seen applicants light up when asked about a paper still in review because they remember every data pull, every late-night draft revision, every argument over inclusion criteria. That authenticity plays better than a sleepy recitation of a poster from MS1.
The data shows committees are not just scoring what you have finished. They are estimating what you will be like in residency. Will you finish QI projects? Will you contribute to case reports? Will you respond to deadlines? A manuscript in review is indirect evidence that you know how to move work across checkpoints.
Use that strategically. If you list it, be ready with a 30-second and 90-second explanation. Tight, specific, honest. No rambling. No pretending you ran the whole project if you cleaned the database and wrote half the methods. Precision builds trust.
And that is the bigger story here. Listing "in review" manuscripts is not about gaming optics. It is about accurately displaying active output in a system that rewards visible momentum.
Key Takeaways
The data shows three durable advantages to listing "in review" manuscripts on your residency CV.
First, it signals an active research pipeline. In competitive specialties, visible scholarly momentum correlates with stronger interview and match outcomes, often in the 20-25% relative range compared with applicants who show no publication activity.
Second, it adds credibility. "In review" means a manuscript has usually cleared initial editorial screening, placing it beyond the weakest tier of submissions and giving committees a legitimate peer-validation signal.
Third, it improves visibility. Standardized status language makes your application easier to parse, easier to search, and easier to trust.
My position is simple: if the manuscript is genuinely in review, list it. Use accurate citation format. Include dates. Update statuses promptly. Do not undersell real work out of nervousness. Residency selection is already noisy enough. Your job is to present clean signal.
